H. Hermeking

Human Proteinpedia enables sharing of human protein data (2008)

Mathivanan, S., Ahmed, M., Ahn, N. G., Alexandre, H., Amanchy, R., Andrews, P. C., ...

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer (2008)

Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Körner, H., ...

Digital karyotyping reveals frequent inactivation of the Dystrophin/DMD gene in malignant melanoma (2007)

Korner, H., Epanchintsev, A., Berking, C., Schuler-Thurner, B., Speicher, M. R., Menssen, A., ...

Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach (2007)

Koch, H. B., Zhang, R., Verdoodt, B., Bailey, A., Zhang, C. D., Yates, J. R., ...

c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1 (2007)

Menssen, A., Epanchintsev, A., Lodygin, D., Rezaei, N., Jung, P., Verdoodt, B., ...

Induction of Cullin 7 by DNA damage attenuates p53 function (2007)

Jung, P., Verdoodt, B., Bailey, A., Yates, J. R., Menssen, A., Hermeking, H.

p53 enters the MicroRNA world (2007)

Hermeking, H.

DNA stool test for colorectal cancer: Hypermethylation of the secreted frizzled-related protein-1 gene (2007)

Zhang, W., Bauer, M., Croner, R. S., Pelz, J. O. W., Lodygin, D., Hermeking, H., ...

Differential regulation of microRNAs by p53 revealed by massively parallel Sequencing - miR-34a is a p53 target that induces apoptosis and G(1)-arrest (2007)

Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., ...

Inducible microRNA expression by an all-in-one episomal vector system (2006)

Epanchintsev, A., Jung, P., Menssen, A., Hermeking, H.

14-3-3 proteins and cancer biology (2006)

Hermeking, H.

14-3-3 proteins in cell cycle regulation (2006)

Hermeking, H., Benzinger, A.

Epigenetic silencing of 14-3-3sigma in cancer (2006)

Lodygin, D., Hermeking, H.

Characterization of 14-3-3sigma dimerization determinants (2006)

Verdoodt, B., Benzinger, A., Popowicz, G. M., Holak, T. A., Hermeking, H.

Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer (2005)

Benzinger,A., Muster,N., Koch,H. B., Yates,J. R., Hermeking,H.

Functional epigenomics identifies genes frequently silenced in prostate cancer (2005)

Lodygin,D., Epanchintsev,A., Menssen,A., Diebold,J., Hermeking,H.

The crystal structure of the non-liganded 14-3-3 sigma protein: insights into determinants of isoform specific ligand binding and dimerization (2005)

Benzinger,A., Popowicz,G. M., Joy,J. K., Majumdar,S., Holak,T. A., Hermeking,H.

The role of epigenetic inactivation of 14-3-3 sigma in human cancer (2005)

Lodygin,D., Hermeking,H.

Downregulation of 14-3-3 sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation (2005)

Mhawech,P., Benz,A., Cerato,C., Greloz,V., Assaly,M., Desmond,J. C., ...

Extracellular 14-3-3 sigma protein: A potential mediator of epithelial-mesenchymal interactions (2005)

Hermeking, H.

Downregulation of 14-3-3 sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation (2005)

Mhawech, P., Benz, A., Cerato, C., Greloz, V., Assaly, M., Desmond, J. C., ...

Functional epigenomics identifies genes frequently silenced in prostate cancer (2005)

Lodygin, D., Epanchintsev, A., Menssen, A., Diebold, J., Hermeking, H.

Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer (2005)

Benzinger, A., Muster, N., Koch, H. B., Yates, J. R., Hermeking, H.

The crystal structure of the non-liganded 14-3-3 sigma protein: insights into determinants of isoform specific ligand binding and dimerization (2005)

Benzinger, A., Popowicz, G. M., Joy, J. K., Majumdar, S., Holak, T. A., Hermeking, H.

The role of epigenetic inactivation of 14-3-3 sigma in human cancer (2005)

Lodygin, D., Hermeking, H.

Cancer Drug Target Identification by SAGE, LongSAGE and Digital Karyotyping (2005)

Hermeking, H.

Prostate cancer is characterized by epigenetic silencing of 14-3-3 sigma expression (2004)

Lodygin,D., Diebold,J., Hermeking,H.

Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc (2004)

Pawar,S. A., Szentirmay,M. N., Hermeking,H., Sawadogo,M.

Loss of 14-3-3S expression in basal cell carcinoma by epigenetic si-lencing via CPG-methylation (2004)

Herzinger,T., Lodygin,D., Yazdi,A. S., Hermeking,H.

Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc (2004)

Pawar, S. A., Szentirmay, M. N., Hermeking, H., Sawadogo, M.

Loss of 14-3-3S expression in basal cell carcinoma by epigenetic si-lencing via CPG-methylation (2004)

Herzinger, T., Lodygin, D., Yazdi, A. S., Hermeking, H.

Prostate cancer is characterized by epigenetic silencing of 14-3-3 sigma expression (2004)

Lodygin, D., Diebold, J., Hermeking, H.

Principles of Molecular Oncology (2004)

Hermeking, H.

Analysis of 14-3-3 sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma (2003)

Lodygin,D., Yazdi,A. S., Sander,C. A., Herzinger,T., Hermeking,H.

Serial analysis of gene expression and cancer (2003)

Hermeking, H.

Serial analysis of gene expression has been widely used to characterize gene expression patterns associated with tumor formation. These studies resulted in the identification of tumor-specific...

Analysis of 14-3-3 sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma (2003)

Lodygin, D., Yazdi, A. S., Sander, C. A., Herzinger, T., Hermeking, H.

The 14-3-3 cancer connection (2003)

Hermeking, H.

The c-MYC oncogene as a cancer drug target (2003)

Hermeking, H.

Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner (2002)

Lodygin,D., Menssen,A., Hermeking,H.

Using microarray analysis, we have detected downregulation of several components of the cGMP signaling pathway during replicative senescence of primary human diploid fibroblasts (HDFs). Therefore,...

Characterization of epithelial senescence by serial analysis of gene expression: Identification of genes potentially involved in prostate cancer (2002)

Untergasser,G., Koch,K. B., Menssen,A., Hermeking,H.

Evasion of cellular senescence is required for the immortal phenotype of tumor cells. The tumor suppressor genes p16(INK4A), pRb, and p53 have been implicated in the induction of cellular senescence....

Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes (2002)

Menssen,A., Hermeking,H.

To identify target genes of the oncogenic transcription factor c-MYC, serial analysis of gene expression (SAGE) was performed after adenoviral expression of c-MYC in primary human umbilical vein...

Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner (2002)

Lodygin,D., Hermeking,H.

Characterization of epithelial senescence by serial analysis of gene expression: Identification of genes potentially involved in prostate cancer (2002)

Untergasser, G., Koch, K. B., Menssen, A., Hermeking, H.

Evasion of cellular senescence is required for the immortal phenotype of tumor cells. The tumor suppressor genes p16(INK4A), pRb, and p53 have been implicated in the induction of cellular senescence....

Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes (2002)

Menssen, A., Hermeking, H.

To identify target genes of the oncogenic transcription factor c-MYC, serial analysis of gene expression (SAGE) was performed after adenoviral expression of c-MYC in primary human umbilical vein...

Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner (2002)

Lodygin, D., Menssen, A., Hermeking, H.

Using microarray analysis, we have detected downregulation of several components of the cGMP signaling pathway during replicative senescence of primary human diploid fibroblasts (HDFs). Therefore,...

Serial analysis of gene expression and cancer (2002)

Hermeking, H.

Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner (2002)

Lodygin, D., Hermeking, H.

Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts.

Hermeking, H, Wolf, D A, Kohlhuber, F, Dickmanns, A, Billaud, M, Fanning, E, ...

Stably transfected NIH 3T3-L1 mouse fibroblasts (L1 cells) expressing the simian virus 40 large tumor antigen (LTAg) maintain c-myc expression and proliferation in low serum, whereas cells expressing...

Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts.

Hermeking, H, Wolf, D A, Kohlhuber, F, Dickmanns, A, Billaud, M, Fanning, E, ...

Stably transfected NIH 3T3-L1 mouse fibroblasts (L1 cells) expressing the simian virus 40 large tumor antigen (LTAg) maintain c-myc expression and proliferation in low serum, whereas cells expressing...

Consensus-interferon and platelet-derived growth factor adversely regulate proliferation and migration of Kaposi's sarcoma cells by control of c-myc expression.

Köster, R., Blatt, L. M., Streubert, M., Zietz, C., Hermeking, H., Brysch, W., ...

Platelet-derived growth factor-B (PDGF-B) is a potent paracrine-acting mitogen in Kaposi's sarcoma (KS) lesions. Interferon-alpha is widely used for clinical treatment of KS. Here we show that...